Skip to main content
Log in

The bioequivalence of standard sumatriptan tablets and two encapsulated forms of sumatriptan

  • Letters to the Editor
  • Published:
International Journal of Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Milton KA, Kleinermans D, Scott N, Cooper JDH. The bioequivalence of standard sumatriptan tablets and two encapsulated forms of sumatriptan. Int J Pharm Med 2001; 15:21–26.

    Article  Google Scholar 

  2. FDA Draft Guidance on Bioequivalence Studies; August 1999.

  3. O’Quinn SV et al. Headache 2000; 40:202.

    Google Scholar 

  4. Fuseau E et al. Clinical Therapeutics 2001; 23:242–251.

    Article  PubMed  CAS  Google Scholar 

  5. Goadsby PJ et al. Neurology 2000; 54:156–163.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McNeal, S., O’Quinn, S. & Scott, A. The bioequivalence of standard sumatriptan tablets and two encapsulated forms of sumatriptan. International Journal of Pharmaceutical Medicine 15, 197–198 (2001). https://doi.org/10.1097/00124363-200108000-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1097/00124363-200108000-00007

Keywords

Navigation